Scaling and automating early detection of cognitive diseases with AI

AI is reshaping healthcare. Neuroscience is no exception. This session takes you inside MoCA Cognition, a global leader in cognitive assessment based in Montreal. Their mission: to push the boundaries of early detection for Alzheimer’s and related cognitive diseases. We explore their journey into transformative AI in partnership with Osedea, a leader in AI solutions.

We’ll explore how 15 purpose-built AI models are helping automate clinical assessments, reduce bias, and scale access to cognitive screening globally. This session is about more than technology. It’s about the hurdles faced, the breakthroughs unlocked, and the vision for AI-driven neuropsychology that lies ahead.

MoCA’s platform is trusted by more than two million clinicians, researchers, and healthcare professionals worldwide. They’re rewriting the future of the evaluation process by weaving computer vision, natural language processing, and large language models into their process.